Filters
Other countries
Results: 1 to 19 of 19
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
SLC6A9 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Supplemental Metabolic Newborn Screening Panel Invitae United States | 253 | 189 |
|
Invitae Comprehensive Neurometabolic Disorders Panel Invitae United States | 351 | 249 |
|
PreventionGenetics, part of Exact Sciences United States | 11 | 11 |
|
Leukodystrophy and Leukoencephalopathy Panel PreventionGenetics, part of Exact Sciences United States | 202 | 212 |
|
Invitae Elevated Glycine Panel (including Glycine Encephalopathy) Invitae United States | 13 | 12 |
|
Invitae Neurotransmitter Disorders Panel Invitae United States | 52 | 44 |
|
Invitae Hereditary Hyperekplexia Panel Invitae United States | 23 | 13 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Nonketotic hyperglycinemia / glycine encephalopathy panel. 9-gene NGS panel. Genologica Medica Spain | 8 | 9 |
|
GLYT1 Encephalopathy: gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Glycine Encephalopathy: gene deletion/duplication CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 1 |
|
Glycine Encephalopathy: gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 3 |
|
Glycine transporter 1 deficiency (SLC6A9) Amsterdam UMC, Location AMC Laboratory Genetic Metabolic Diseases, LGMD Netherlands | 1 | 1 |
|
Results: 1 to 19 of 19
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.